As COVID-19 continues to spread, ESMO encourages the oncology community to run collaborative initiatives to answer important questions: How to manage cancer care in patients with suspected or confirmed COVID-19? How to identify risk factors and outcomes associated to the infection? How is COVID-19 impacting on oncology professionals? And others which become relevant as the situation evolves.
Impact of COVID-19 on Cancer Service Delivery
A survey launched by the University of Melbourne and Peter MacCallum Cancer Centre to understand the global impact of COVID-19 on cancer services. The survey is open to medical oncologists, radiation oncologists, surgical oncologists and trainees in these fields, and aims to explore how the clinical management of cancer patients has changed during the COVID-19 pandemic.
ESMO COVID-19 and CAncer REgistry Protocol
By pooling real-world data, the ESMOCoCARE Registry aims to quickly gather data and information about treatment approaches specifically focusing on the impact of SARS-CoV-2 on cancer patients who are suspected or confirmed to have the novel coronavirus disease (COVID19).
A better understanding of the unique effects of COVID-19 on patients with cancer and cancer survivors will allow to disseminate information and guidance for this particularly vulnerable group of patients and, ultimately, to propose approaches to mitigate the risks related to COVID-19 in cancer patients.
EHA initiative in collaboration with ESMO
The most urgent question and almost impossible to answer: which therapies should be administered/continued and which should be deferred/stopped? A survey amongst experts in their respective fields to get a better understanding of the risks. The survey will close on 27 April 2020.
How are you reacting to the COVID-19 outbreak? An ESMO Resilience Task Force survey
The ESMO Resilience Task Force, in collaboration with the ESMO Young Oncologists Committee, the ESMO Women for Oncology Committee, the ESMO Leaders Generation Programme Alumni Members and the OncoAlert Network, will carry out a series of global surveys to evaluate how oncologists and other oncology professionals across the world are affected by the challenges posed by the COVID-19 pandemic, assessing changes to routine practices, well-being and current levels of support.
TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion) registry for thoracic cancers
A global consortium designed to gather information on patients with thoracic cancer infected with COVID-19 regardless of therapies administered. The initiative currently involves more than 100 investigators worldwide.
Main contact: Jennifer Whisenant, Vanderbilt-Ingram Cancer Center, Nashville, US. - E-Mail